Last year, doctors in Berlin made an unprecedented announcement: They declared an HIV patient who had undergone an HIV-resistant bone marrow transplant to be cured of his disease. Now, doctors in Texas are hoping to build on that success story by screening stored umbilical cord blood for HIV-resistant stem cells that could be transplanted into patients.
The treatment would benefit only a small group of people who have both HIV and certain cancers, and the chance of finding a suitable genetic match between stem cellsand patients is low. It's also risky – almost one-third of patients who undergo the bone marrow transplant procedure die. But the research is part of a wider push to develop drug-free ways of living with HIV.
Click to expand...